Popular Trials
Behavioural Intervention
Integrated Treatment for Smoking Cessation After Acute Coronary Syndrome
This trial will test whether a single, integrated treatment that targets both depressed mood and smoking is more effective than usual care in reducing post-acute coronary syndrome mortality.
Electronic Cigarette
E-Cigarettes + NRT and Counseling for Smoking in Opioid Use Disorder
This trial will compare e-cigarettes with NRT + counseling to help reduce smoking among people in opioid use disorder treatment. It will help provide a tool to reduce tobacco harm in a hard-to-treat population.
Health Literacy Interventions for Smoking
This trial is examining whether different types of messages emphasizing the health consequences of smoking, written at a 5th to 6th grade reading level, will have different effects on smokers with varying levels of health literacy.
Popular Filters
Trials for Smoking Cessation Patients
Behavioural Intervention
TMS for Smoking Cessation in Schizophrenia
This trial uses a magnetic pulse device to help people with schizophrenia stop smoking. It targets specific brain areas involved in both conditions. The goal is to see if this method is effective for this particular group. This method has been shown to decrease cigarette consumption in schizophrenia patients.
Behavioral Intervention
Smoke-Free Policy Support for Smoking Cessation
This trial will test two ways to reduce exposure to secondhand smoke in residential buildings. One targets all building residents, while the other targets smokers specifically, with the goal of reducing smoking and exposure to secondhand smoke.
Behavioural Intervention
Smoking Cessation Treatment for Head & Neck Cancer Patients
This trial is designed to study and compare the effectiveness of two types of counseling for cancer patients who want to quit smoking: Acceptance and Commitment Therapy (ACT) and Motivational and Behavioral Counseling (MBC).
Trials for Smoking Addiction Patients
Sleep Management for Nicotine Addiction
This trial will test the hypothesis that chronotype (preference for morning or evening activity) and impaired sleep impact cigarette usage, smoking dependence, urge/craving, and withdrawal differently in blacks compared to whites.
Behavioural Intervention
Transcranial Magnetic Stimulation for Smoking Addiction
This trial aims to find the best way to use brain stimulation to help smokers by testing different protocols. They will also assess how these protocols affect decision-making and cravings. The study will involve two sessions and
Phase 3 Trials
Behavioral Intervention
Withdrawal Regulation Training for Smoking Cessation
This trial will test a new smoking cessation treatment to see if it is effective and how it works. The results could help improve existing treatments and reduce smoking-related deaths in the US.
Trials With No Placebo
NMDA Receptor Antagonist
Ketamine vs Midazolam for Tobacco Use Disorder
This trial tests how different drugs affect smoking habits and cravings in people who are not trying to quit. Participants receive an injection of either ketamine, midazolam, dexmedetomidine, or a saltwater solution. The study aims to see if these drugs can help reduce cravings and withdrawal symptoms.
Behavioural Intervention
TMS for Smoking Cessation in Schizophrenia
This trial uses a magnetic pulse device to help people with schizophrenia stop smoking. It targets specific brain areas involved in both conditions. The goal is to see if this method is effective for this particular group. This method has been shown to decrease cigarette consumption in schizophrenia patients.
Behavioral Intervention
Smoke-Free Policy Support for Smoking Cessation
This trial will test two ways to reduce exposure to secondhand smoke in residential buildings. One targets all building residents, while the other targets smokers specifically, with the goal of reducing smoking and exposure to secondhand smoke.
Sleep Management for Nicotine Addiction
This trial will test the hypothesis that chronotype (preference for morning or evening activity) and impaired sleep impact cigarette usage, smoking dependence, urge/craving, and withdrawal differently in blacks compared to whites.
View More Related Trials
Frequently Asked Questions
Introduction to smoking
What are the top hospitals conducting smoking research?
When it comes to tackling the complex issue of smoking, several top hospitals are at the forefront of conducting groundbreaking clinical trials. In Houston, M D Anderson Cancer Center leads the charge with eight active smoking trials aimed at understanding and addressing this harmful addiction. Interestingly, this renowned institution has not conducted any previous smoking trials, highlighting their commitment to pushing boundaries and exploring new avenues in research. Similarly, Brown University School of Public Health in Providence is actively involved in three ongoing smoking trials but does not have a historical record of conducting such studies. This signifies their dedication to making significant strides forward in combating smoking-related issues.
In Philadelphia, the University of Pennsylvania is also playing a vital role by currently running three active clinical trials focused on smoking cessation and related concerns. Like the previous institutions mentioned above, they have yet to conduct any past studies specifically targeting smoking. Meanwhile, another prominent Houston-based hospital named University of Texas MD Anderson Cancer Center is actively engaged in three ongoing smoking trials as well.
Last but certainly not least, the Medical University of South carolina located in Charleston is lending its expertise towards combating tobacco addiction through three current clinical trials dedicated to understanding various aspects surrounding this global health concern.
These esteemed medical centers shed light on an important aspect: while there may be no historical records for these institutions' involvement with specific types of research like cigarette-smoking-related investigations up until now; their ongoing efforts demonstrate an unwavering commitment towards exploring innovative solutions that could potentially transform how we approach issues associated with tobacco use disorder.
Which are the best cities for smoking clinical trials?
When it comes to smoking clinical trials, several cities have emerged as key players in research and development. Houston, Texas takes the lead with 19 active trials focusing on the effects of cigarettes, nicotine replacement therapies (NRT), and innovative interventions like the MASP app combined with NRT. Miami, Florida follows closely behind with 15 ongoing studies examining cigarette use and treatment options such as cisplatin. Honolulu, Hawaii also contributes to this field with eight active trials investigating cisplatin's impact on smoking cessation. These cities provide individuals interested in participating in smoking-related clinical trials access to cutting-edge research that aims to improve tobacco cessation strategies and reduce associated health risks.
Which are the top treatments for smoking being explored in clinical trials?
Several potential breakthroughs are being investigated in clinical trials to combat smoking addiction. Leading the pack is varenicline, a medication that has shown promise with its effectiveness and safety profile. Also making waves is cytisine, an affordable and accessible treatment option that holds significant potential for smoking cessation. Finally, nicotine replacement therapies (NRTs) such as patches, gum, and lozenges continue to be explored for their efficacy in helping individuals quit smoking. These innovative treatments offer hope for smokers looking to break free from addiction and improve their overall health and well-being.
What are the most recent clinical trials for smoking?
Recent clinical trials are shedding light on innovative approaches to address smoking addiction. One such study involves active rTMS, a non-invasive brain stimulation technique that shows promise in aiding individuals who want to quit smoking. Additionally, research is underway to understand the optimal timing for initiating nicotine replacement therapy as part of standard treatment for smoking cessation. Another trial focuses on contingency management strategies that provide incentives to encourage smokers towards quitting. With these advancements, healthcare professionals can offer more effective interventions and support those struggling with tobacco addiction on their journey towards better health.
What smoking clinical trials were recently completed?
In recent times, there have been several completed clinical trials focused on smoking cessation. These trials aimed to explore various strategies and interventions to assist individuals in quitting smoking. While the specific details of these trials may vary, their common goal was to contribute to our understanding of effective approaches for tobacco addiction treatment. By evaluating different methods and interventions, researchers strive to improve smoking cessation outcomes and ultimately reduce the harmful impact of tobacco use on public health.